M., Z. Kolar, R. Novotny, et al. 1997. Induction of apoptosis and regression of spontaneous dog melanoma following in vivo application of synthetic cyclin‐dependent kinase inhibitor olomoucine. Anticancer Drugs 8:1007–1013.
271 Halle, M., I. Bodin, P. Tornvall, et al. 2009. Timing of radiotherapy in head and neck free flap reconstruction – A study of postoperative complications. J Plast Reconstr Aesthet Surg 62:889–895.
272 Hammer, A.S., C.G. Couto, R.D. Ayl, et al. 1994. Treatment of tumor‐bearing dogs with actinomycin D. J Vet Intern Med 8:236–239.
273 Hammer, A.S., C.G. Couto, J. Filppi, et al. 1991. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J Vet Intern Med 5:160–166.
274 Hammer, A., D. Getzy, G. Ogilvie, et al. 2001. Salivary gland neoplasia in the dog and cat: Survival times and prognostic factors. J Am Anim Hosp Assoc 37:478–482.
275 Hanna, F. 2005. Multiple myelomas in cats. J Feline Med Surg 7:275–287.
276 Hansen, K.S., C. Weisse, A.C. Berent, et al. 2012. Use of a self‐expanding metallic stent to palliate esophageal neoplastic obstruction in a dog. J Am Vet Med Assoc 240:1202–1207.
277 Hardie, E.M., J.A. Barsanti, and C. Rawlings. 1984. Complications of prostatic surgery. J Am Anim Hosp Assoc 20:50–56.
278 Hargis, A.M., P.J. Ihrke, W.L. Spangler, et al. 1992. A retrospective clinicopathologic study of 212 dogs with cutaneous hemangiomas and hemangiosarcomas. Vet Pathol 29:316–328.
279 Harvey, H.J., E.G. Macewen, D. Braun, et al. 1981. Prognostic criteria for dogs with oral melanoma. J Am Vet Med Assoc 178:580–582.
280 Hasinoff, B.B. 2006. Dexrazoxane use in the prevention of anthracycline extravasation injury. Future Oncol 2:15–20.
281 Havlicek, M., R.S. Straw, V. Langova, et al. 2009. Intra‐operative cisplatin for the treatment of canine extremity soft tissue sarcomas. Vet Comp Oncol 7:122–129.
282 Hayashi, A., H. Tanaka, T. Tajima, et al. 2013. A spayed female cat with squamous cell carcinoma in the uterine remnant. J Vet Med Sci 75:391–393.
283 Heidner, G.L., R.L. Page, M.C. McEntee, et al. 1991. Treatment of canine appendicular osteosarcoma using cobalt 60 radiation and intraarterial cisplatin. J Vet Intern Med 5:313–316.
284 Heller, D.A., M.E. Stebbins, T.L. Reynolds, et al. 2005. A retrospective study of 87 cases of canine soft tissue sarcomas, 1986–2001. Int J Appl Res Vet Med 3:81–87.
285 Henry, C.J., D.L. Mccaw, S.E. Turnquist, et al. 2003. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clin Cancer Res 9:906–911.
286 Hermo, G.A., P. Torres, G.V. Ripoll, et al. 2008. Perioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: A pilot study. Vet J 178:103–108.
287 Hermo, G.A., E. Turic, D. Angelico, et al. 2011. Effect of adjuvant perioperative desmopressin in locally advanced canine mammary carcinoma and its relation to histologic grade. J Am Anim Hosp Assoc 47:21–27.
288 Hershey, A.E., I.D. Kurzman, L.J. Forrest, et al. 1999. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: Proof of principle using dogs with spontaneously occurring tumors as a model. Clin Cancer Res 5:2653–2659.
289 Hershey, A.E., K.U. Sorenmo, M.J. Hendrick, et al. 2000. Prognosis for presumed feline vaccine‐associated sarcoma after excision: 61 cases (1986–1996). J Am Vet Med Assoc 216:58–61.
290 Higginbotham, M.L., D.L. McCaw, J.K. Roush, et al. 2013. Intermittent single‐agent doxorubicin for the treatment of canine B‐cell lymphoma. J Am Anim Hosp Assoc 49:357–362.
291 Higgs, P. and A. Hibbert. 2012. Managing hyperthyroidism in cats. Vet Rec 171:225–226.
292 Higuchi, T., G.N. Burcham, M.O. Childress, et al. 2013. Characterization and treatment of transitional cell carcinoma of the abdominal wall in dogs: 24 cases (1985–2010). J Am Vet Med Assoc 242:499–506.
293 Higuchi, T., N. Dervisis, and B.E. Kitchell. 2010. Efficacy of doxorubicin for histiocytic sarcoma in dogs. In Proceedings of the Veterinary Cancer Society, 30th Annual Conference. San Diego, USA, October 29–November 1, 2010, p. 51.
294 Hill, K.E., J.P. Chambers, B.R. Jones, et al. 2015a. Regional variations in percutaneous absorption of methimazole: An in vitro study on cat skin. J Vet Pharmacol Ther 38:616–618.
295 Hill, K.E., J.P. Chambers, B.R. Jones, et al. 2015b. Trans‐pinnal movement of methimazole: An in vitro study showing that methimazole can cross from the inner to outer pinna of cats. J Feline Med Surg 17:1005–1011.
296 Hill, K.E., M.A. Gieseg, D. Kingsbury, et al. 2011. The efficacy and safety of a novel lipophilic formulation of methimazole for the once daily transdermal treatment of cats with hyperthyroidism. J Vet Intern Med 25:1357–1365.
297 Hill, K.E., P.C. Mills, B.R. Jones, et al. 2015c. Percutaneous absorption of methimazole: An in vitro study of the absorption pharmacokinetics for two different vehicles. J Vet Pharmacol Ther 38:581–589.
298 Hillers, K.R., S.E. Lana, C.R. Fuller, et al. 2007. Effects of palliative radiation therapy on nonsplenic hemangiosarcoma in dogs. J Am Anim Hosp Assoc 43:187–192.
299 Hitt, M.E., D.P. Shaw, P.M. Hogan, et al. 1987. Radiation treatment for thymoma in a dog. J Am Vet Med Assoc 190:1187–1190.
300 Hobson, H.P., M.R. Brown, and K.S. Rogers. 2006. Surgery of metastatic anal sac adenocarcinoma in five dogs. Vet Surg 35:267–270.
301 Hodge, S.C., D. Degner, R. Walshaw, et al. 2011. Vascularized ulnar bone grafts for limb‐sparing surgery for the treatment of distal radial osteosarcoma. J Am Anim Hosp Assoc 47:98–111.
302 Hoelzler, M.G., J.R. Bellah, and M.C. Donofro. 2001. Omentalization of cystic sublumbar lymph node metastases for long‐term palliation of tenesmus and dysuria in a dog with anal sac adenocarcinoma. J Am Vet Med Assoc 219:1729–1731, 1708.
303 Hoffman, S.B., A.R. Yoder, and L.A. Trepanier. 2002. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats. J Vet Pharmacol Ther 25:189–193.
304 Hoffmann, G., S.L. Marks, J. Taboada, et al. 2003. Transdermal methimazole treatment in cats with hyperthyroidism. J Feline Med Surg 5:77–82.
305 Hogge, G.S., J.K. Burkholder, J. Culp, et al. 1999. Preclinical development of human granulocyte‐macrophage colony‐stimulating factor‐transfected melanoma cell vaccine using established canine cell lines and normal dogs. Cancer Gene Ther 6:26–36.
306 Holt, P.E. 2007. Evaluation of transanal endoscopic treatment of benign canine rectal neoplasia. J Small Anim Pract 48:17–25.
307 Holt, P.E. and P. Durdey. 1999. Transanal endoscopic treatment of benign canine rectal tumours: Preliminary results in six cases (1992 to 1996). J Small Anim Pract 40:423–427.
308 Holtermann, N., M. Kiupel, M. Kessler, et al. 2016. Masitinib monotherapy in canine epitheliotropic lymphoma. Vet Comp Oncol 14 (Suppl 1):127–135.
309 Huber, D.J., S.J. Withrow, S.M. Larue, et al. 2000. Limb sparing with intraoperative radiation for bone sarcomas. Vet Surg 29:446–456.
310 Hui, T.Y., D.S. Bruyette, G.E. Moore, et al. 2015. Effect of feeding an iodine‐restricted diet in cats with spontaneous hyperthyroidism. J Vet Intern Med 29:1063–1068.
311 Hunley, D.W., G.N. Mauldin, K. Shiomitsu, et al. 2010. Clinical outcome in dogs with nasal tumors treated with intensity‐modulated radiation therapy. Can Vet J 51:293–300.
312 Irvine‐Smith, G.S. and R.G. Lobetti. 2006. Ipsilateral vascularised ulnar transposition autograft for limb‐sparing surgery of the distal radius in 2 dogs with osteosarcoma. J S Afr Vet Assoc 77:150–154.
313 Isidoro‐Ayza, M., A. Lloret, M. Bardagi, et al. 2014. Superficial necrolytic dermatitis in a dog with an insulin‐producing pancreatic islet cell carcinoma. Vet